Hospital Morales Meseguer

Murcia 30008

0 studies enrolling now · 5 studies all time

What they study most

Autoimmune Diseases, Blood Coagulation Disorder, Blood Platelet Disorder, Chronic Lymphocytic Leukemia, Hematologic Diseases, Hemorrhage, Hemorrhagic Disorders, ITP - Immune Thrombocytopenia, Immune System Diseases, Immune Thrombocytopenia, Lymphoma, Non-Hodgkin, Multiple Myeloma

Studies at this site

• The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) — Withdrawn before enrolling
• Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer — Completed
• Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma — Completed
• Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) — Completed
• Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia — Stopped early